Sharon Peng
Hematology & Oncology · Roseville, CANPI 1902156557
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $968 of the $1,609 with a category attached, or 60.1%. It is spread thinly across 28 manufacturers, the largest accounting for just 21.9%. Reporting peaked in 2022 at $807 and has fallen 90.4% since, to $77 in 2023. That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.
Across 54 payments — averaging $29.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$352
- Amgen$260
- Incyte Corporation$125
- E.r. Squibb & Sons, L.L.C.$95
- AVEO Pharmaceuticals, Inc.$82
- AstraZeneca$80
- plus $615 from 22 others
What the payments were for
- Food & beverage$96860%
- Education$64140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $352 |
| Amgen | 5 | $260 |
| Incyte Corporation | 2 | $125 |
| E.r. Squibb & Sons, L.L.C. | 4 | $95 |
| AVEO Pharmaceuticals, Inc. | 1 | $82 |
| AstraZeneca | 2 | $80 |
| Lilly USA, LLC | 1 | $75 |
| Johnson & Johnson | 3 | $51 |
| Rigel Pharmaceuticals, Inc. | 2 | $49 |
| Gilead(2 entities) | 3 | $45 |
| Bayer | 2 | $44 |
| GSK | 2 | $34 |
| Merck | 2 | $33 |
| Seagen Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $25 |
| Pfizer | 2 | $24 |
| G1 Therapeutics, Inc. | 1 | $24 |
| Sanofi | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $20 |
| Foundation Medicine, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XGEVA$106
How this compares
$1,609 in reported general payments places this provider in the 35th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Roseville
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.